sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
26-Oct-2014 00:28
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 326-350 out of 897.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>

Public Release: 4-Mar-2014
Global Public Health
Fighting against HIV in the Central African Republic -- the importance of perseverance
According to Pierre-Marie David of the University of Montreal's Faculty of Pharmacy, stock-outs of antiretroviral drugs in recent years in the Central African Republic have had a dramatic impact on the health of HIV-infected people. These shortages have also created mistrust among patients toward the political and medical actors responsible for the fight against HIV/AIDS.
Méos, SIDAction

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal

Public Release: 3-Mar-2014
New constipation treatment under study for Parkinson's patients
Constipation can be another uncomfortable problem for patients with Parkinson's disease that standard treatment won't relieve, researchers say.
Rhythm

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 3-Mar-2014
Nature
Novel drug treatment protects primates from deadly Marburg virus
For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.
Joint Science and Technology Office for Chemical and Biological Defense, Defense Threat Reduction Agency

Contact: Caree Vander Linden
Caree.VanderLinden@us.army.mil
US Army Medical Research Institute of Infectious Diseases

Public Release: 3-Mar-2014
Nature
New research on potent HIV antibodies has opened up possibilities
The discovery of how a KwaZulu-Natal woman's body responded to her HIV infection by making potent antibodies (called broadly neutralizing antibodies, because they are able to kill multiple strains of HIV from across the world), was reported today by the CAPRISA consortium of AIDS researchers jointly with scientists from the United States.

Contact: Vivienne Rowland
Vivienne.Rowland@wits.ac.za
27-011-717-1017
University of the Witwatersrand

Public Release: 3-Mar-2014
Europe is joining forces against neglected parasitic diseases
The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria. The researchers have a common objective: to develop new drugs against the parasites that cause these diseases.
European Commission

Contact: Raymond Pierce
Raymond.Pierce@pasteur-lille.fr
33-320-877-783
INSERM (Institut national de la santé et de la recherche médicale)

Public Release: 28-Feb-2014
Journal of Virology
Light zaps viruses: How photosensitization can stop viruses from infecting cells
Researchers find evidence that photosensitizing a virus's membrane covering can inhibit its ability to enter cells and potentially lead to the development of stronger, cheaper medications to fight a host of tough viruses.
National Institutes of Health, Fundação para a Ciência e a Tecnologia

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences

Public Release: 28-Feb-2014
PLOS Neglected Tropical Diseases
Indonesia's competitiveness at risk from neglected diseases of poverty
Indonesia has seen impressive economic and development growth. Sustaining these gains, however, may not be possible without aggressively addressing neglected tropical diseases, which affect the majority of Indonesians. Neglected tropical diseases are 'one of the most potent forces' of extreme poverty and inequality in Indonesia, Dr. Peter Hotez, president of the Sabin Vaccine Institute, and Dr. Lorenzo Savioli, director of the Department of Control of Neglected Tropical Diseases at the World Health Organization, among others, explain in PLOS Neglected Tropical Diseases.

Contact: Deborah Elson
deborah.elson@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 27-Feb-2014
New research to revolutionize healthcare through remote monitoring of patients
Researchers from the University of Surrey have today launched a new program of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers. A €6 million grant from the European Union will fund a large 1,000 patient trial in England, Austria, Greece, Holland, Ireland and Norway, with the hope that the new system will be integrated into routine cancer care in the future.
European Union

Contact: Peter La
p.la@surrey.ac.uk
01-483-689-191
University of Surrey

Public Release: 26-Feb-2014
Journal of Experimental Medicine
Experimental treatment developed at UCLA eradicates acute leukemia in mice
A team of scientists from the University of California Los Angeles Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles

Public Release: 26-Feb-2014
Applied and Environmental Microbiology
Harvested rainwater harbors pathogens
South Africa has been financing domestic rainwater harvesting tanks in informal low-income settlements and rural areas in five of that nation's nine provinces. But pathogens inhabit such harvested rainwater, potentially posing a public health hazard, especially for children and immunocompromised individuals, according to a team from the University of Stellenbosch. The research was published ahead of print in Applied and Environmental Microbiology.

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 26-Feb-2014
Health Affairs
Improved prescribing and reimbursement practices in China
Pay-for-performance has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact. A new study, released today as a Web First by Health Affairs, examines the effects of pay-for-performance, combined with capitation, in China's largely rural Ningxia Province.

Contact: Sue Ducat
sducat@projecthope.org
301-841-9962
Health Affairs

Public Release: 26-Feb-2014
New England Journal of Medicine
Febrile illnesses in children most often due to viral infections
Most children ill with fever in Tanzania suffer from a viral infection. A research team led by Dr. Valerie D'Acremont from the Swiss Tropical and Public Health Institute in Basel systematically assessed the causes of febrile illnesses in Tanzanian children. According to the results, in most cases a treatment with antimalarials or antibiotics is not required. The finding has the potential to improve the rational use of antimicrobials, and thus reduce costs and drug resistance.

Contact: Christian Heuss
christian.heuss@unibas.ch
41-612-848-683
Swiss Tropical and Public Health Institute

Public Release: 25-Feb-2014
mBio
Vinegar kills tuberculosis and other mycobacteria
The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the US reports in mBio, the online open-access journal of the American Society for Microbiology.

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 23-Feb-2014
Nature
A key protein is discovered as essential for malaria parasite transmission to mosquitos
Scientists studying the sexual transformation of the malaria parasite have solved a long-standing mystery in parasite biology. Two research teams have independently discovered that a single protein acts as the master genetic switch that triggers the development of male and female sexual forms of the malaria parasite. The discovery has important implications for human health.
National Institutes of Health, Damon Runyon Cancer Research Foundation, Wellcome Trust, European Comission, Biotechnology and Biological Sciences Research Council, Spanish Ministry of Science and Innovation, and others

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State

Public Release: 20-Feb-2014
Developing countries face 'leading medical scourge of developed countries'
Chronic illness, already a major and expensive problem in developed countries, is rapidly increasing in developing countries, adding to the longstanding burden caused by high rates of infectious diseases. However, poor countries will not be able to afford the costly medical technologies that wealthy countries use to treat chronic conditions, including heart disease, stroke, cancer, pulmonary disease, and diabetes, writes Daniel Callahan, cofounder of the Hastings Center.

Contact: Susan Gilbert
gilberts@thehastingscenter.org
845-424-4040 x244
The Hastings Center

Public Release: 20-Feb-2014
PLOS ONE
Younger people, men and those without children more likely to drop out of HIV care in South Africa
Analysis carried out by an academic at Royal Holloway, University of London has revealed that younger people, men and those without children are more likely to stop attending clinics for HIV treatment in South Africa.

Contact: Sophia Haque
Sophia.Haque@rhul.ac.uk
01-784-443-552
Royal Holloway, University of London

Public Release: 19-Feb-2014
Lancet
Malaria maps reveal that 184 million Africans still live in extremely high-risk areas despite decade of control efforts
Forty African countries showed reductions in malaria transmission between 2000-2010, but despite this progress, more than half (57 percent) of the population in countries endemic for malaria continue to live in areas of moderate to intense transmission, with infection rates over 10 percent. The findings are based on a series of prevalence maps for malaria published this week in the Lancet.
Wellcome Trust

Contact: Meera Senthilingam
m.senthilingam@wellcome.ac.uk
020-761-17262
Wellcome Trust

Public Release: 18-Feb-2014
Journal of Clinical Pharmacology
Malnutrition decreases effectiveness of HIV treatment in pregnant African women
In Uganda the prescription of three antiretroviral drugs, which aim to suppress the virus to prevent disease progression, have resulted in huge reductions in HIV mortality rates. However, disease is not the only scourge in Uganda, and a new study in The Journal of Clinical Pharmacology explores the impact food insecurity may have on treating pregnant women.

Contact: Ben Norman
Sciencenewsroom@wiley.com
44-012-437-70375
Wiley

Public Release: 18-Feb-2014
Journal of Midwifery & Women's Health
'It takes a village' -- Community-based methods for improving maternal and newborn health
A series of studies are published in a special supplement that presents results of the Maternal and Newborn Health in Ethiopia Partnership -- a three-year pilot program funded by the Bill and Melinda Gates Foundation with the goal of improving the health of Ethiopian mothers and their newborns. This special issue of the Journal of Midwifery & Women's Health is published by Wiley on behalf of the American College of Nurse-Midwives.
Bill and Melinda Gates Foundation

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 18-Feb-2014
Vaccine
Revolutionary meningitis vaccine breaks cold chain barrier, extends reach to remotest Africa
The first mass vaccination campaign conducted in Africa with authorization to keep the vaccine unrefrigerated up to temperatures of 39 degrees C (102.2 degrees F) provided complete coverage with little wastage, according to a study by researchers from the global health nonprofit PATH and the World Health Organization. If the findings from the meningitis A vaccine campaign in Benin are widely adopted, the study suggests vaccine protection could be extended to areas far removed from access to electricity.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Meningitis Vaccine Project

Public Release: 17-Feb-2014
Chemist gets US patent for solution to resistance problem
A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

Contact: Jes Andersen
jean@science.ku.dk
45-30-50-65-82
University of Copenhagen

Public Release: 16-Feb-2014
PLOS ONE
Malaria vaccine development paves way for protective therapy
Scientists have made a significant contribution towards the development of a vaccine to prevent malaria.
European Union

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh

Public Release: 16-Feb-2014
2014 AAAS Annual Meeting
Obesity in Samoa: A global harbinger?
Solving the mystery of how the population of the Samoan archipelago developed one of the world's highest rates of obesity is important not only for addressing the problem but also possibly for predicting the course of obesity in other parts of the developing world. Brown University epidemiologist Stephen McGarvey, who has been studying the Samoan pandemic for years, will speak at the AAAS annual meeting in Chicago at 1:30 p.m. US CT Feb. 16, 2014.

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 14-Feb-2014
Journal of Thoracic Oncology
High frequency of EGFR mutations found in Asian population
Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors. A recent study has found that, within the Asian population, the frequency of EGFR mutations associated with other demographic and clinical characteristics is higher than previously reported.

Contact: Kristin Richeimer
kristin.richeimer@iaslc.org
720-325-2953
International Association for the Study of Lung Cancer

Public Release: 14-Feb-2014
2014 AAAS Annual Meeting
South African healthcare workers face greater risk for TB, HIV
A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Contact: Brian Lin
brian.lin@ubc.ca
604-818-5685
University of British Columbia

Showing releases 326-350 out of 897.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>